My watch list
my.bionity.com  
Login  

Therapeutic Antibodies

Companies Therapeutic Antibodies

Memo Therapeutics AG, Switzerland

Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis. Its MemoMABTM platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antib more

Calypso Biotech SA, Switzerland

Calypso Biotech is an innovative biopharmaceutical company based in Geneva, Switzerland and founded in 2013 as a spin-off from Merck Serono, a global leader in auto-immune diseases and biologics. Calypso Biotech was initially financed through a 2.5 million euro seed-fund managed by MS Ventures. A hi more

adivo GmbH, Germany

adivo is a German biotech company based in Martinsried near Munich specializing in generating spe-cies-specific therapeutic antibodies for companion animals. The adivo team aims to initially address high medical needs in dogs including cancer and chronic inflammation, with the potential of expand-in more

News Therapeutic Antibodies

  • BioVaria Startup Awards go to iRASP Therapeutics and OrganoTherapeutics

    This year’s virtual BioVaria from 26 to 28 April brought together 250 life-science innovators to hear about the most exciting technologies and start-ups to emerge from publicly funded European research, and to initiate partnerships between science and business. With 75 licensable projects and 16 sel more

  • Charles River Laboratories Acquires Distributed Bio

    Charles River Laboratories International, Inc. announced that it acquired of Distributed Bio, Inc. on December 31, 2020. The acquisition marks the culmination of an exclusive partnership between these companies that was initiated in October 2018. Based in South San Francisco, California, Distributed more

  • How the immune system becomes blind to cancer cells

    T cells play a huge role in our immune system's fight against modified cells in the body that can develop into cancer. Phagocytes and B cells identify changes in these cells and activate the T cells, which then start a full-blown program of destruction. This functions well in many cases - unless the more

All news on therapeutic antibodies

Publications Therapeutic Antibodies

  • Complement-Dependent Cytotoxicity Assay

    A useful feature of therapeutic antibodies is the ability to kill the cells to which they bind. Antibodies are capable of mediating cell killing in a variety of ways. Apoptosis, complement-mediated mechanisms, and antibody-dependent cellular cytotoxicity are all effects that can be assayed to chara more

  • Complement-Dependent Cytotoxicity Assay

    A useful feature of therapeutic antibodies is the ability to kill the cells to which they bind. Antibodies are capable of mediating cell killing in a variety of ways. Apoptosis, complement-mediated mechanisms, and antibody-dependent cellular cytotoxicity are all effects that can be assayed to chara more

  • Assessment of Antibody-Dependent Cellular Cytotoxicity by Flow Cytometry

    A useful feature of therapeutic antibodies is the ability to kill the cells to which they bind. Antibodies are capable of mediating cell killing in a variety of ways. Apoptosis, complement-mediated mechanisms, and antibody-dependent cellular cytotoxicity (ADCC) are all effects that can be assayed t more

All publications on therapeutic antibodies
Related topics

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE